Alivus Life Sciences receives ₹25.61 lakh CGST order for FY21-22
- Alivus Life Sciences received a CGST order for FY21-22 totaling ₹25.61 lakh in tax
- Penalty amount equals the tax demand at ₹25,61,400, plus applicable interest
- Order issued under Section 74(1) of CGST Act by Vadodara-II Commissionerate
- Company states no material financial or operational impact from the order
- Management is assessing options to file an appeal against the ruling
*this image is generated using AI for illustrative purposes only.
Alivus Life Sciences Limited received a Central Goods & Service Tax (CGST) order dated October 8, 2026, involving a total tax demand of ₹25.61 lakh for the fiscal years 2020-21 and 2021-22.
The order was passed under Section 74(1) of the CGST Act, 2017 by the Office of the Assistant Commissioner, Division-VIII, Ankleshwar, Vadodara-II Commissionerate. The demand comprises the principal tax amount of ₹25,61,400 along with an equivalent penalty amounting to ₹25,61,400, plus applicable interest.
Regulatory Disclosure Details
The company disclosed this development to BSE and NSE under Regulation 30 of the SEBI Listing Regulations. The disclosure highlights that the order was received around 6:00 pm on October 8, 2026. The specific nature of the action is an order issued for alleged contraventions during FY21 and FY22.
| Particulars | Details |
|---|---|
| Authority | CGST Department, Vadodara-II Commissionerate |
| Section | Section 74(1) of CGST Act, 2017 |
| Period | FY 2020-21 and FY 2021-22 |
| Tax Amount | ₹25,61,400 |
| Penalty Amount | ₹25,61,400 |
| Interest | Applicable |
Company Response and Impact
Alivus Life Sciences stated that there is no material impact on its financials or operations due to this intimation. The company noted that the order is currently appealable. Management indicated it will conduct an assessment to exercise its right to appeal against the decision.
The company, formerly known as Glenmark Life Sciences Limited, continues to operate from its corporate office in Mumbai and registered office in Solapur. The compliance officer, Rudalf Correa, signed the digital filing confirming these details.
Historical Stock Returns for Alivus Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.41% | -2.07% | -2.84% | +22.97% | +40.14% | 0.0% |
Will Alivus Life Sciences file an appeal against the CGST order, and what is the expected timeline for the appellate authority's decision?
How might the rebranding from Glenmark Life Sciences to Alivus Life Sciences influence regulatory scrutiny or compliance audits in the coming quarters?
Could this tax demand trigger a broader review of GST compliance for other entities within the same corporate group or sector?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
